HealthGood news: COVID-19 vaccine skepticism is waning. Bad news: That might not be enough
In much of the developed world, people are more confident in the idea of taking the COVID-19 vaccine when it becomes available, a host of new data shows.
January 22, 2021
From Worksheet, our new newsletter about productivity
NewslettersThe pandemic reveals the surprising differences in how men and women network
Pandemic networks have shrunk by 17%—almost entirely among men.
January 20, 2021
COVID-19 vaccine
The Biden administration
TechWhy the COVID vaccine rollout is a massive tech challenge
A big piece of the puzzle comes down to issues of reporting and sharing data around the United States.
January 22, 2021
Brainstorm Reinvent
From the magazine
MagazineElon Musk’s rocket ride
SpaceX is soaring. Tesla is roaring. How the world’s most creative and controversial CEO is transforming one industry after another—and why he’s Fortune’s Businessperson of the Year.
December 2, 2020
Unemployment
Quarterly Investment Guide
FinanceHow tech stocks ‘ate’ the stock market
JPMorgan estimates the true weighting in the market for tech stocks is closer to 40%—while those companies account for 6% of nominal GDP and employ just 2% of the country’s workers.
January 21, 2021
Leadership
Features
TechKnow when to fold ’em: How a company best known for playing games used A.I. to solve one of biology’s greatest mysteries
DeepMind, a sister company of Google, has achieved a breakthrough that’s likely to accelerate the discovery of new medicines and vaccines. It’s also a glimpse of how A.I. is starting to revolutionize science.
November 30, 2020